Devin Blass

Devin Blass

Chief Tech/Sci/R&D Officer at LONGEVERON INC.

Net worth: 299 292 $ as of 30/06/2026

40 year
Health Technology
Health Services
Consumer Services

Profile

Mr. Devin Blass is a Chief Technology Officer & Senior Vice President at Longeveron, Inc. Mr. Blass was previously employed as a Senior Vice President-Comprehensive Cell Solutions by New York Blood Center, Inc., a Vice President-Technical Operations by Talaris Therapeutics, Inc., a Head-Cell Manufacturing Operations by Bellicum Pharmaceuticals, Inc., and a Director-Commercial Program Manufacturing by Mesoblast, Inc. He received his undergraduate degree from Texas State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/07/2026 4,25,735 ( 1.41% ) 299 292 $ 30/06/2026

Devin Blass active positions

CompaniesPositionStart
LONGEVERON INC. Chief Tech/Sci/R&D Officer 02/12/2024

Former positions of Devin Blass

CompaniesPositionEnd
Corporate Officer/Principal -
BELLICUM PHARMACEUTICALS, INC. Corporate Officer/Principal -
Corporate Officer/Principal -
TOUE BIOPAR Chief Operating Officer -
See the detail of Devin Blass's experience

Training of Devin Blass

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

2

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology